About Agatsa
Agatsa is a company based in Noida (India) founded in 2014 by Neha Rastogi and Rahul Rastogi. Agatsa has raised $10.04 million across 12 funding rounds from investors including Sun Pharma, Artha India Ventures and Marwah Steels. The company has 83 employees as of April 08, 2024. Agatsa operates in a competitive market with competitors including iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
- Headquarter Noida, India
- Employees 83 as on 08 Apr, 2024
- Founders Neha Rastogi, Rahul Rastogi
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Agatsa Software Private Limited
- Date of Incorporation 16 Mar, 2010
- Jurisdiction Noida, Uttar Pradesh, India
-
Annual Revenue
$133.41 K (USD)151.86as on Mar 31, 2023
-
Net Profit
-$1.39 M (USD)-230.24as on Mar 31, 2023
-
EBITDA
-$1.24 M (USD)-241.88as on Mar 31, 2023
-
Total Equity Funding
$10.04 M (USD)
in 12 rounds
-
Latest Funding Round
$1.44 M (USD), Series A
Oct 17, 2023
-
Investors
Sun Pharma
& 72 more
-
Employee Count
83
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Agatsa
Unlock access to complete
Unlock access to complete
Funding Insights of Agatsa
Agatsa has successfully raised a total of $10.04M across 12 strategic funding rounds. The most recent funding activity was a Series A round of $1.44 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Agatsa
Agatsa has secured backing from 73 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Sun Pharma, Artha India Ventures and Marwah Steels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investor network investing in early-stage startups
|
Locked | Locked | Locked | |
|
Multiple-stage venture capital investments are managed by Haystack.
|
Locked | Locked | Locked | |
|
PE & VC focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Agatsa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Agatsa
Investment portfolio details for Agatsa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Agatsa
Detailed financials for Agatsa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Agatsa Comparisons
Peer comparison for Agatsa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Agatsa
Agatsa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
AI-based EGC data capture and analysis platform
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Online health and wellness tracking and training platform
|
Detailed competitors of Agatsa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Agatsa
Complete news archive for Agatsa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Agatsa
Agatsa was founded in 2014.
Agatsa is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Rahul Rastogi is the current CEO of Agatsa. They have also founded this company.
Agatsa is a funded company, having raised a total of $10.04M across 12 funding rounds to date.
As of Apr 08, 2024, the latest employee count at Agatsa is 83.
Annual revenue of Agatsa is $133.41K as on Mar 31, 2023.
Founded in 2014 in Noida, India, the company operates in the health monitoring sector. Portable electrocardiogram devices and heart health monitors are produced, along with touch-based monitors, sleep aids, and tracking applications. Real-time ECG monitoring, blood pressure measurement, and sleep analysis are enabled by the devices. Shareable reports are generated from data, and medical history is backed up in the cloud.
Agatsa's top competitors include AliveCor, iRhythm Tech and Biotricity.
Agatsa has 73 investors. Key investors include Sun Pharma, Artha India Ventures, Marwah Steels, Technology Development Board, and Texport.
The valuation of Agatsa is $12.62M as of Oct 2023.